Vaccine & Boosters

Before you pick a time: 

  • Please ensure we have accurate email and cell phone contact information, so that we may reach you in a timely manner if necessary.
  • If you are currently participating in or have participated in a COVID vaccine study, please contact your study coordinator before scheduling.
  • Those 5+ who are moderately or severely immunocompromised should get an additional primary shot of Pfizer-BioNTech COVID-19 vaccine. Immunosuppressed patients 12+ qualify for a total of 4 doses (3 primary doses, followed by 1 booster dose 3 months later). Contact your primary care provider with questions or to schedule a vaccine appointment.

Approval has now been granted for the administration of "mix and match" vaccines--a booster different from the vaccine originally administered. If you are interested in pursuing this option, please call (832) 632-6731 or email C19Vacsch@utmb.edu for assistance.

BEGIN THE SCHEDULING PROCESS BELOW:

Select desired dose of the COVID-19 Vaccine:

   

  • Patient is 18 years or older. (Pfizer/Moderna)

    Please Note: Multiple vaccine sites may be listed. Scroll down to ensure that you have selected a site convenient to you.

    VT 1265

    If you need assistance determining if an individual meets the criteria outlined by the CDC and Texas Department of State Health Services to schedule a COVID-19 vaccine, or if you have any COVID-19 vaccine questions, please call (832) 632-6731 or email C19Vacsch@utmb.edu.

  • Please review dosing, timing and age guidelines for the general population and for immunocompromised individuals to determine if/when the patient qualifies for a second dose.

    • Patient is 18 years or older. Select which vaccine the patient would you like to receive:

        

      • Please Note: Multiple vaccine sites may be listed. Scroll down to ensure that you have selected a site convenient to you.

        VT 1266

      • Please Note: Multiple vaccine sites may be listed. Scroll down to ensure that you have selected a site convenient to you.

        VT 1267

      If you need assistance determining if an individual meets the criteria outlined by the CDC and Texas Department of State Health Services to schedule a COVID-19 vaccine, or if you have any COVID-19 vaccine questions, please call (832) 632-6731 or email C19Vacsch@utmb.edu.

  • Please review dosing, timing and age guidelines for the general population and for immunocompromised individuals to determine if/when the patient qualifies for a second dose.

    • Patient is 18 years or older. Select which vaccine the patient would you like to receive:

        

      • Please Note: Multiple vaccine sites may be listed. Scroll down to ensure that you have selected a site convenient to you.

        VT 1293

      • Please Note: Multiple vaccine sites may be listed. Scroll down to ensure that you have selected a site convenient to you.

        VT 1295

      If you need assistance determining if an individual meets the criteria outlined by the CDC and Texas Department of State Health Services to schedule a COVID-19 vaccine, or if you have any COVID-19 vaccine questions, please call (832) 632-6731 or email C19Vacsch@utmb.edu.

Reporting an Adverse Vaccine Event

To ensure safety, there’s a significant effort to track possible side effects and adverse events from the COVID-19 vaccines. Use these links if you experience anything concerning or unexpected with the vaccine.

Report your event that required medical attention to UTMB (UTMB Employees Only)
Report your event to HHS (Vaccine Adverse Event Reporting System-VAERS)
Use the V-Safe Tool (app from the CDC)

COVID-19 Testing

UTMB is offering expedited COVID-19 testing for our workforce through MyChart (click to log in). Details on how to schedule an employee COVID test using MyChart are below for both current MyChart users and employees new to MyChart (must be on UTMB network to view instructions).
What do my COVID-19 test results mean?

UTMB Safety Requirements

NEW Top Buttons

Masking
Sick or Exposed
Travel Information
Visitation Policy

Latest Updates

  • Vaccines available for children ages 6 months to 5 years

    Many parents, caregivers and clinicians have been waiting for a COVID-19 vaccine for younger children. Now that the CDC has approved the vaccine for children ages 6 months to 5 years, UTMB will begin offering the vaccine at our pediatric clinics beginning Monday, June 27.

    Read more

  • Clinical Task Force: Updated COVID safety measures to take effect on June 7

    Due to a continued increase in COVID infections in the community this week (test positivity of >20%) together with a modest increase in COVID-related hospitalizations and rising infection among employees and students, new COVID precautions are being implemented effective June 7, 2022.

    Read more

  • COVID-19 Clinical Task Force: Modifications to precautions due to increasing number of infections

    The rate of COVID infection has continued to increase in our region as well as among our patients and UTMB workforce. Although rates of severe infection and hospitalization due to COVID remain stable and low, caution is advised to keep our employees and patients safe from COVID infection during this current wave. The following COVID precautions are effective immediately. If the rates of COVID admissions and infections among our workforce increase further, additional precautions may be implemented.

    Read more

  • Vaccination Task Force: CDC recommends FDA-approved single-dose booster for children ages 5-11

    On May 17, 2022, the U.S. Food and Drug Administration authorized the use of a single booster dose of the Pfizer-BioNTech COVID-19 Vaccine for children 5 through 11 years of age at least five months after completing a primary series with the Pfizer-BioNTech COVID-19 vaccine. (See the FDA announcement.) The Centers for Disease Control and Prevention approved the booster for this age group on May 19, 2022. CDC now recommends that children ages 5 through 11 years should receive a booster shot 5 months after their initial Pfizer-BioNTech vaccination series. (See the CDC announcement.)

    Read more

Find Past Updates >>